Optibrium, Intellegens and Medicines Discovery Catapult combine their expertise in drug discovery and AI research.
Dr Sally Price, Head of Cell and Translational Science at Medicines Discovery Catapult (MDC) has been named in BioBeat’20 Movers & Shakers in BioBusiness 2020.
Today, the University of Exeter and Medicines Discovery Catapult (MDC) announce their strategic partnership to accelerate medicines Research & Development (R&D), creating value for the sector and enhancing translational skills.
Global mental health care company, COMPASS Pathways has joined the Psychiatry Consortium, bringing additional expertise and insights to the group.
The Alderley Park Lighthouse Lab in Cheshire, which plays a key role in the UK Government’s national COVID testing, last week processed its 4 millionth test since its launch at the start of the pandemic.
The national programme, to develop and progress start-up oncology projects, is being launched by Bruntwood SciTech at Alderley Park – the UK’s largest single site life science campus – with funding from Innovate UK and Cancer Research UK.
National UK SPINE initiative created to help us stay healthy in later years.
The Alderley Park Lighthouse Lab in Cheshire plays a key role in supporting the government’s drive to increase UK testing capacity.
Validated research tool to be used to predict disease severity and individual therapeutic response to COVID-19 in aid of rapid vaccine and drug development.
Sixfold Bioscience and Medicines Discovery Catapult (MDC) awarded Innovate UK grant to pursue ground-breaking project.
See how we can help support you with your next drug discovery project.
Speak to us